Humana Target Price

Where could HUM trade next? Consensus target price: $460.

Get informed when a big investor buys or sells

+ Follow

Share Price

$413.33

Average Target Price

$460.37

11.4% upside

27 analysts in the last 4 months

High: $596 | Low: $300

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2026-10-13	Mizuho Securities	$495	19.8% upside
2026-10-12	Raymond James	$520	25.8% upside
2026-10-12	Truist FinancialDavid MacDonald	$475	14.9% upside
2026-10-12	Oppenheimer	$525	27% upside
2026-10-12	UBS	$495	19.8% upside
2026-10-09	Oppenheimer	$475	14.9% upside
2026-10-09	UBS	$596	44.2% upside
2026-10-09	Robert W. BairdMichael Ha	$596	44.2% upside
2026-10-09	Barclays	$582	40.8% upside
2026-10-07	Raymond JamesSarah James	$460	11.3% upside
2026-09-25	Barclays	$515	24.6% upside
2026-08-24	Wolfe ResearchJustin Lake	$450	8.9% upside
2026-08-04	Morgan Stanley	$370	10.5% downside
2026-07-31	Barclays	$407	1.5% downside
2026-07-30	Robert W. Baird	$390	5.6% downside
2026-07-30	Leerink Partners	$513	24.1% upside
2026-07-30	Guggenheim	$471	14% upside
2026-07-30	OppenheimerMichael Wiederhorn	$405	2% downside
2026-07-30	UBS	$405	2% downside
2026-07-30	Piper Sandler	$463	12% upside
2026-07-29	Evercore ISI	$480	16.1% upside
2026-07-20	Jefferies	$410	0.8% downside
2026-07-14	Truist FinancialDavid MacDonald	$415	0.4% upside
2026-07-13	Wells FargoStephen Baxter	$502	21.5% upside
2026-07-09	RBC Capital	$415	0.4% upside
2026-07-07	Cantor Fitzgerald	$300	27.4% downside
2026-07-07	Raymond JamesSarah James	$300	27.4% downside
2026-06-08	Mizuho Securities	$390	5.6% downside
2026-06-04	Morgan Stanley	$249	39.8% downside
2026-06-03	Bernstein	$425	2.8% upside
2026-06-01	Truist FinancialDavid MacDonald	$320	22.6% downside
2026-05-26	Barclays	$344	16.8% downside
2026-05-22	UBS	$320	22.6% downside
2026-05-20	Mizuho Securities	$335	19% downside
2026-05-20	Deutsche Bank	$441	6.7% upside
2026-05-15	Morgan StanleyErin Wright	$217	47.5% downside
2026-05-13	Piper Sandler	$254	38.5% downside
2026-05-01	Raymond James	$260	37.1% downside
2026-04-30	Barclays	$180	56.5% downside
2026-04-30	UBS	$262	36.6% downside
2026-04-30	Guggenheim	$269	34.9% downside
2026-04-30	Truist FinancialDavid MacDonald	$270	34.7% downside
2026-04-30	Oppenheimer	$260	37.1% downside
2026-04-30	Deutsche Bank	$235	43.1% downside
2026-04-30	RBC CapitalBen Hendrix	$246	40.5% downside
2026-04-08	Evercore ISI	$195	52.8% downside
2026-04-08	Mizuho Securities	$258	37.6% downside
2026-02-18	Wells Fargo	$206	50.2% downside
2026-02-17	Truist Financial	$200	51.6% downside
2026-02-13	Deutsche BankGeorge Hill	$180	56.5% downside

Humana (HUM) FAQ

Humana (HUM) currently reports a target price of $460. Use the charts on this page to explore Humana's target price history and peer comparisons.

Analysts' average 12-month price target for Humana is $460, about 11.4% upside from the current share price of $413.33. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $460, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Humana, and consider following HUM for alerts when major investors trade the stock.

Humana is classified in the Healthcare sector. On target price, it currently shows $460. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HUM with unrelated industries.